nodes	percent_of_prediction	percent_of_DWPC	metapath
Anagrelide—PDE3A—penis—chronic kidney failure	0.158	0.44	CbGeAlD
Anagrelide—PDE3A—blood plasma—chronic kidney failure	0.0549	0.153	CbGeAlD
Anagrelide—CYP1A2—urine—chronic kidney failure	0.0465	0.13	CbGeAlD
Anagrelide—CYP1A2—Lidocaine metabolism—CYP3A4—chronic kidney failure	0.0406	0.0633	CbGpPWpGaD
Anagrelide—PDE3A—Nitric oxide stimulates guanylate cyclase—NOS1—chronic kidney failure	0.0273	0.0425	CbGpPWpGaD
Anagrelide—PDE3A—cardiovascular system—chronic kidney failure	0.0254	0.0708	CbGeAlD
Anagrelide—CYP1A2—blood plasma—chronic kidney failure	0.0243	0.0677	CbGeAlD
Anagrelide—PDE3A—blood—chronic kidney failure	0.0201	0.056	CbGeAlD
Anagrelide—CYP1A2—Synthesis of epoxy (EET) and dihydroxyeicosatrienoic acids (DHET)—CYP2C19—chronic kidney failure	0.0169	0.0264	CbGpPWpGaD
Anagrelide—CYP1A2—Synthesis of (16-20)-hydroxyeicosatetraenoic acids (HETE)—CYP2C19—chronic kidney failure	0.0154	0.024	CbGpPWpGaD
Anagrelide—CYP1A2—Aflatoxin B1 metabolism—CYP3A4—chronic kidney failure	0.0149	0.0233	CbGpPWpGaD
Anagrelide—PDE3A—Nitric oxide stimulates guanylate cyclase—NOS3—chronic kidney failure	0.0131	0.0204	CbGpPWpGaD
Anagrelide—PDE3A—G alpha (s) signalling events—CRHR1—chronic kidney failure	0.0115	0.018	CbGpPWpGaD
Anagrelide—CYP1A2—renal system—chronic kidney failure	0.0114	0.0317	CbGeAlD
Anagrelide—CYP1A2—Xenobiotics—CYP2B6—chronic kidney failure	0.0113	0.0177	CbGpPWpGaD
Anagrelide—PDE3A—Platelet homeostasis—NOS1—chronic kidney failure	0.0106	0.0166	CbGpPWpGaD
Anagrelide—PDE3A—G alpha (s) signalling events—PTH—chronic kidney failure	0.0106	0.0165	CbGpPWpGaD
Anagrelide—CYP1A2—Synthesis of epoxy (EET) and dihydroxyeicosatrienoic acids (DHET)—CYP1A1—chronic kidney failure	0.00998	0.0156	CbGpPWpGaD
Anagrelide—CYP1A2—Xenobiotics—CYP2C18—chronic kidney failure	0.00982	0.0153	CbGpPWpGaD
Anagrelide—CYP1A2—digestive system—chronic kidney failure	0.00934	0.026	CbGeAlD
Anagrelide—CYP1A2—Synthesis of (16-20)-hydroxyeicosatetraenoic acids (HETE)—CYP1A1—chronic kidney failure	0.00909	0.0142	CbGpPWpGaD
Anagrelide—CYP1A2—blood—chronic kidney failure	0.0089	0.0248	CbGeAlD
Anagrelide—PDE3A—G alpha (s) signalling events—CRH—chronic kidney failure	0.00884	0.0138	CbGpPWpGaD
Anagrelide—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCG1—chronic kidney failure	0.00884	0.0138	CbGpPWpGaD
Anagrelide—CYP1A2—Tryptophan metabolism—ACAT1—chronic kidney failure	0.00878	0.0137	CbGpPWpGaD
Anagrelide—PDE3A—G alpha (s) signalling events—NPS—chronic kidney failure	0.00838	0.0131	CbGpPWpGaD
Anagrelide—PDE3A—G alpha (s) signalling events—DRD1—chronic kidney failure	0.00822	0.0128	CbGpPWpGaD
Anagrelide—CYP1A2—Xenobiotics—CYP2C19—chronic kidney failure	0.00814	0.0127	CbGpPWpGaD
Anagrelide—CYP1A2—Tamoxifen metabolism—CYP2C19—chronic kidney failure	0.00783	0.0122	CbGpPWpGaD
Anagrelide—CYP1A2—Fatty Acid Omega Oxidation—CYP3A4—chronic kidney failure	0.0077	0.012	CbGpPWpGaD
Anagrelide—CYP1A2—Metapathway biotransformation—NAT8—chronic kidney failure	0.00758	0.0118	CbGpPWpGaD
Anagrelide—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP2B6—chronic kidney failure	0.00741	0.0116	CbGpPWpGaD
Anagrelide—CYP1A2—Estrogen metabolism—CYP3A4—chronic kidney failure	0.007	0.0109	CbGpPWpGaD
Anagrelide—CYP1A2—Estrogen Receptor Pathway—CYP1A1—chronic kidney failure	0.00677	0.0106	CbGpPWpGaD
Anagrelide—CYP1A2—Aflatoxin activation and detoxification—CYP3A4—chronic kidney failure	0.00671	0.0105	CbGpPWpGaD
Anagrelide—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCC3—chronic kidney failure	0.0067	0.0105	CbGpPWpGaD
Anagrelide—CYP1A2—Xenobiotics—CYP3A4—chronic kidney failure	0.00644	0.01	CbGpPWpGaD
Anagrelide—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCC2—chronic kidney failure	0.00642	0.01	CbGpPWpGaD
Anagrelide—PDE3A—Hemostasis—OLR1—chronic kidney failure	0.00625	0.00975	CbGpPWpGaD
Anagrelide—CYP1A2—Estrogen Receptor Pathway—PPARA—chronic kidney failure	0.00619	0.00966	CbGpPWpGaD
Anagrelide—CYP1A2—Tamoxifen metabolism—CYP3A4—chronic kidney failure	0.00619	0.00966	CbGpPWpGaD
Anagrelide—PDE3A—G alpha (s) signalling events—AVP—chronic kidney failure	0.00606	0.00945	CbGpPWpGaD
Anagrelide—CYP1A2—Melatonin metabolism and effects—CYP2C19—chronic kidney failure	0.00605	0.00943	CbGpPWpGaD
Anagrelide—CYP1A2—Tryptophan metabolism—DDC—chronic kidney failure	0.00599	0.00935	CbGpPWpGaD
Anagrelide—CYP1A2—Fatty Acid Omega Oxidation—CYP1A1—chronic kidney failure	0.00573	0.00894	CbGpPWpGaD
Anagrelide—CYP1A2—Estrogen metabolism—CYP1A1—chronic kidney failure	0.00522	0.00814	CbGpPWpGaD
Anagrelide—PDE3A—Hemostasis—SLC7A9—chronic kidney failure	0.00518	0.00808	CbGpPWpGaD
Anagrelide—PDE3A—Platelet homeostasis—NOS3—chronic kidney failure	0.00509	0.00794	CbGpPWpGaD
Anagrelide—CYP1A2—Tryptophan metabolism—CYP2C18—chronic kidney failure	0.00504	0.00787	CbGpPWpGaD
Anagrelide—CYP1A2—Xenobiotics—CYP1A1—chronic kidney failure	0.0048	0.00748	CbGpPWpGaD
Anagrelide—CYP1A2—Cytochrome P450 - arranged by substrate type—CYP2B6—chronic kidney failure	0.0047	0.00734	CbGpPWpGaD
Anagrelide—CYP1A2—Oxidation by Cytochrome P450—CYP2B6—chronic kidney failure	0.00464	0.00724	CbGpPWpGaD
Anagrelide—CYP1A2—Tamoxifen metabolism—CYP1A1—chronic kidney failure	0.00461	0.00719	CbGpPWpGaD
Anagrelide—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP3A4—chronic kidney failure	0.00421	0.00657	CbGpPWpGaD
Anagrelide—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCA1—chronic kidney failure	0.00414	0.00646	CbGpPWpGaD
Anagrelide—CYP1A2—Cytochrome P450 - arranged by substrate type—CYP2C18—chronic kidney failure	0.00408	0.00636	CbGpPWpGaD
Anagrelide—PDE3A—G alpha (s) signalling events—POMC—chronic kidney failure	0.00403	0.00628	CbGpPWpGaD
Anagrelide—CYP1A2—Oxidation by Cytochrome P450—CYP2C18—chronic kidney failure	0.00403	0.00628	CbGpPWpGaD
Anagrelide—CYP1A2—Arachidonic acid metabolism—CYP2C19—chronic kidney failure	0.00391	0.0061	CbGpPWpGaD
Anagrelide—CYP1A2—Phase 1 - Functionalization of compounds—CYP2B6—chronic kidney failure	0.00381	0.00595	CbGpPWpGaD
Anagrelide—CYP1A2—Melatonin metabolism and effects—EDN1—chronic kidney failure	0.0038	0.00593	CbGpPWpGaD
Anagrelide—CYP1A2—Arachidonic acid metabolism—PTGS1—chronic kidney failure	0.00358	0.00558	CbGpPWpGaD
Anagrelide—CYP1A2—Melatonin metabolism and effects—CYP1A1—chronic kidney failure	0.00356	0.00556	CbGpPWpGaD
Anagrelide—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB1—chronic kidney failure	0.00341	0.00532	CbGpPWpGaD
Anagrelide—CYP1A2—Cytochrome P450 - arranged by substrate type—CYP2C19—chronic kidney failure	0.00338	0.00527	CbGpPWpGaD
Anagrelide—CYP1A2—Oxidation by Cytochrome P450—CYP2C19—chronic kidney failure	0.00334	0.0052	CbGpPWpGaD
Anagrelide—CYP1A2—Tryptophan metabolism—CYP3A4—chronic kidney failure	0.00331	0.00516	CbGpPWpGaD
Anagrelide—CYP1A2—Phase 1 - Functionalization of compounds—CYP2C18—chronic kidney failure	0.00331	0.00516	CbGpPWpGaD
Anagrelide—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARA—chronic kidney failure	0.00287	0.00448	CbGpPWpGaD
Anagrelide—CYP1A2—Tryptophan metabolism—CAT—chronic kidney failure	0.00275	0.00429	CbGpPWpGaD
Anagrelide—CYP1A2—Phase 1 - Functionalization of compounds—CYP2C19—chronic kidney failure	0.00274	0.00427	CbGpPWpGaD
Anagrelide—CYP1A2—Cytochrome P450 - arranged by substrate type—CYP3A4—chronic kidney failure	0.00267	0.00417	CbGpPWpGaD
Anagrelide—CYP1A2—Oxidation by Cytochrome P450—CYP3A4—chronic kidney failure	0.00264	0.00411	CbGpPWpGaD
Anagrelide—CYP1A2—Aryl Hydrocarbon Receptor—LPL—chronic kidney failure	0.00255	0.00398	CbGpPWpGaD
Anagrelide—CYP1A2—Phase 1 - Functionalization of compounds—PTGS1—chronic kidney failure	0.00251	0.00391	CbGpPWpGaD
Anagrelide—CYP1A2—Aryl Hydrocarbon Receptor Pathway—CYP1A1—chronic kidney failure	0.00246	0.00384	CbGpPWpGaD
Anagrelide—CYP1A2—Tryptophan metabolism—CYP1A1—chronic kidney failure	0.00246	0.00384	CbGpPWpGaD
Anagrelide—CYP1A2—Aryl Hydrocarbon Receptor—CYP1A1—chronic kidney failure	0.00246	0.00384	CbGpPWpGaD
Anagrelide—PDE3A—Hemostasis—NOS1—chronic kidney failure	0.00238	0.00371	CbGpPWpGaD
Anagrelide—PDE3A—GPCR downstream signaling—CRHR1—chronic kidney failure	0.00237	0.00369	CbGpPWpGaD
Anagrelide—CYP1A2—Arachidonic acid metabolism—CYP1A1—chronic kidney failure	0.0023	0.00359	CbGpPWpGaD
Anagrelide—CYP1A2—Phase 1 - Functionalization of compounds—CYP3A4—chronic kidney failure	0.00217	0.00338	CbGpPWpGaD
Anagrelide—PDE3A—GPCR downstream signaling—PTH—chronic kidney failure	0.00217	0.00338	CbGpPWpGaD
Anagrelide—PDE3A—Signaling by GPCR—CRHR1—chronic kidney failure	0.00215	0.00335	CbGpPWpGaD
Anagrelide—CYP1A2—Biological oxidations—CYP2B6—chronic kidney failure	0.00203	0.00316	CbGpPWpGaD
Anagrelide—CYP1A2—Metapathway biotransformation—CYP2B6—chronic kidney failure	0.002	0.00312	CbGpPWpGaD
Anagrelide—CYP1A2—Cytochrome P450 - arranged by substrate type—CYP1A1—chronic kidney failure	0.00199	0.00311	CbGpPWpGaD
Anagrelide—PDE3A—Signaling by GPCR—PTH—chronic kidney failure	0.00197	0.00307	CbGpPWpGaD
Anagrelide—CYP1A2—Oxidation by Cytochrome P450—CYP1A1—chronic kidney failure	0.00197	0.00307	CbGpPWpGaD
Anagrelide—PDE3A—GPCR downstream signaling—NPY—chronic kidney failure	0.00188	0.00293	CbGpPWpGaD
Anagrelide—CYP1A2—Melatonin metabolism and effects—NFKB1—chronic kidney failure	0.00184	0.00287	CbGpPWpGaD
Anagrelide—PDE3A—GPCR downstream signaling—CRH—chronic kidney failure	0.00181	0.00283	CbGpPWpGaD
Anagrelide—PDE3A—GPCR downstream signaling—OXT—chronic kidney failure	0.00181	0.00283	CbGpPWpGaD
Anagrelide—PDE3A—Signaling Pathways—COL4A5—chronic kidney failure	0.0018	0.00281	CbGpPWpGaD
Anagrelide—CYP1A2—Biological oxidations—CYP2C18—chronic kidney failure	0.00176	0.00274	CbGpPWpGaD
Anagrelide—CYP1A2—Metapathway biotransformation—CYP2C18—chronic kidney failure	0.00173	0.0027	CbGpPWpGaD
Anagrelide—PDE3A—GPCR downstream signaling—NPS—chronic kidney failure	0.00172	0.00268	CbGpPWpGaD
Anagrelide—PDE3A—Signaling by GPCR—NPY—chronic kidney failure	0.00171	0.00266	CbGpPWpGaD
Anagrelide—PDE3A—GPCR downstream signaling—DRD1—chronic kidney failure	0.00169	0.00263	CbGpPWpGaD
Anagrelide—PDE3A—Signaling Pathways—TFDP2—chronic kidney failure	0.00168	0.00261	CbGpPWpGaD
Anagrelide—PDE3A—Signaling by GPCR—CRH—chronic kidney failure	0.00165	0.00257	CbGpPWpGaD
Anagrelide—PDE3A—Signaling by GPCR—OXT—chronic kidney failure	0.00165	0.00257	CbGpPWpGaD
Anagrelide—PDE3A—Signaling Pathways—PIP5K1B—chronic kidney failure	0.00164	0.00256	CbGpPWpGaD
Anagrelide—CYP1A2—Phase 1 - Functionalization of compounds—CYP1A1—chronic kidney failure	0.00161	0.00252	CbGpPWpGaD
Anagrelide—PDE3A—Signaling by GPCR—NPS—chronic kidney failure	0.00156	0.00244	CbGpPWpGaD
Anagrelide—PDE3A—Hemostasis—PLAU—chronic kidney failure	0.00154	0.00241	CbGpPWpGaD
Anagrelide—PDE3A—Signaling by GPCR—DRD1—chronic kidney failure	0.00153	0.00239	CbGpPWpGaD
Anagrelide—CYP1A2—Aryl Hydrocarbon Receptor—RELA—chronic kidney failure	0.00151	0.00235	CbGpPWpGaD
Anagrelide—PDE3A—Signaling Pathways—PGF—chronic kidney failure	0.00149	0.00233	CbGpPWpGaD
Anagrelide—CYP1A2—Cytochrome P450 - arranged by substrate type—POMC—chronic kidney failure	0.00149	0.00232	CbGpPWpGaD
Anagrelide—CYP1A2—Aryl Hydrocarbon Receptor—PTGS2—chronic kidney failure	0.00147	0.00228	CbGpPWpGaD
Anagrelide—CYP1A2—Biological oxidations—CYP2C19—chronic kidney failure	0.00146	0.00227	CbGpPWpGaD
Anagrelide—PDE3A—Hemostasis—F2—chronic kidney failure	0.00144	0.00224	CbGpPWpGaD
Anagrelide—CYP1A2—Metapathway biotransformation—CYP2C19—chronic kidney failure	0.00144	0.00224	CbGpPWpGaD
Anagrelide—PDE3A—Signaling Pathways—PRKAG2—chronic kidney failure	0.0014	0.00219	CbGpPWpGaD
Anagrelide—CYP1A2—Arachidonic acid metabolism—PTGS2—chronic kidney failure	0.00137	0.00214	CbGpPWpGaD
Anagrelide—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL1B—chronic kidney failure	0.00136	0.00213	CbGpPWpGaD
Anagrelide—CYP1A2—Metabolism of lipids and lipoproteins—FABP1—chronic kidney failure	0.00135	0.00211	CbGpPWpGaD
Anagrelide—PDE3A—Signaling Pathways—COL4A3—chronic kidney failure	0.00133	0.00208	CbGpPWpGaD
Anagrelide—CYP1A2—Biological oxidations—PTGS1—chronic kidney failure	0.00133	0.00208	CbGpPWpGaD
Anagrelide—PDE3A—Signaling by GPCR—HBEGF—chronic kidney failure	0.0013	0.00203	CbGpPWpGaD
Anagrelide—CYP1A2—Aryl Hydrocarbon Receptor—NFKB1—chronic kidney failure	0.00127	0.00198	CbGpPWpGaD
Anagrelide—PDE3A—Signaling Pathways—CRHR1—chronic kidney failure	0.00127	0.00198	CbGpPWpGaD
Anagrelide—PDE3A—Hemostasis—IGF1—chronic kidney failure	0.00126	0.00196	CbGpPWpGaD
Anagrelide—PDE3A—GPCR downstream signaling—AVP—chronic kidney failure	0.00124	0.00194	CbGpPWpGaD
Anagrelide—PDE3A—Signaling Pathways—LRP2—chronic kidney failure	0.00122	0.0019	CbGpPWpGaD
Anagrelide—CYP1A2—Phase 1 - Functionalization of compounds—POMC—chronic kidney failure	0.0012	0.00188	CbGpPWpGaD
Anagrelide—PDE3A—Hemostasis—SERPINE1—chronic kidney failure	0.00119	0.00186	CbGpPWpGaD
Anagrelide—PDE3A—Hemostasis—ALB—chronic kidney failure	0.00119	0.00186	CbGpPWpGaD
Anagrelide—PDE3A—GPCR downstream signaling—EDN1—chronic kidney failure	0.00118	0.00184	CbGpPWpGaD
Anagrelide—CYP1A2—Metabolism of lipids and lipoproteins—ACAT1—chronic kidney failure	0.00117	0.00183	CbGpPWpGaD
Anagrelide—PDE3A—GPCR downstream signaling—CCL5—chronic kidney failure	0.00117	0.00183	CbGpPWpGaD
Anagrelide—PDE3A—Signaling Pathways—PTH—chronic kidney failure	0.00116	0.00181	CbGpPWpGaD
Anagrelide—CYP1A2—Aryl Hydrocarbon Receptor—VEGFA—chronic kidney failure	0.00115	0.0018	CbGpPWpGaD
Anagrelide—CYP1A2—Biological oxidations—CYP3A4—chronic kidney failure	0.00115	0.0018	CbGpPWpGaD
Anagrelide—PDE3A—Hemostasis—NOS3—chronic kidney failure	0.00114	0.00178	CbGpPWpGaD
Anagrelide—CYP1A2—Metapathway biotransformation—CYP3A4—chronic kidney failure	0.00114	0.00177	CbGpPWpGaD
Anagrelide—PDE3A—Signaling Pathways—CYBB—chronic kidney failure	0.00113	0.00177	CbGpPWpGaD
Anagrelide—PDE3A—Signaling by GPCR—AVP—chronic kidney failure	0.00113	0.00176	CbGpPWpGaD
Anagrelide—PDE3A—Signaling by GPCR—EDN1—chronic kidney failure	0.00107	0.00168	CbGpPWpGaD
Anagrelide—PDE3A—Signaling Pathways—FGF23—chronic kidney failure	0.00107	0.00167	CbGpPWpGaD
Anagrelide—PDE3A—Signaling by GPCR—CCL5—chronic kidney failure	0.00107	0.00166	CbGpPWpGaD
Anagrelide—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TGFB1—chronic kidney failure	0.00106	0.00165	CbGpPWpGaD
Anagrelide—PDE3A—GPCR downstream signaling—CCR5—chronic kidney failure	0.00106	0.00165	CbGpPWpGaD
Anagrelide—PDE3A—Signaling Pathways—NPY—chronic kidney failure	0.00101	0.00157	CbGpPWpGaD
Anagrelide—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TNF—chronic kidney failure	0.000989	0.00154	CbGpPWpGaD
Anagrelide—CYP1A2—Aryl Hydrocarbon Receptor—TNF—chronic kidney failure	0.000989	0.00154	CbGpPWpGaD
Anagrelide—CYP1A2—Aryl Hydrocarbon Receptor—KRAS—chronic kidney failure	0.000981	0.00153	CbGpPWpGaD
Anagrelide—PDE3A—Signaling Pathways—CRH—chronic kidney failure	0.000973	0.00152	CbGpPWpGaD
Anagrelide—PDE3A—Signaling Pathways—OXT—chronic kidney failure	0.000973	0.00152	CbGpPWpGaD
Anagrelide—PDE3A—Signaling by GPCR—CCR5—chronic kidney failure	0.00096	0.0015	CbGpPWpGaD
Anagrelide—PDE3A—Signaling Pathways—NCF1—chronic kidney failure	0.000932	0.00145	CbGpPWpGaD
Anagrelide—CYP1A2—Metabolism of lipids and lipoproteins—ABCG1—chronic kidney failure	0.000928	0.00145	CbGpPWpGaD
Anagrelide—PDE3A—Signaling Pathways—NPS—chronic kidney failure	0.000923	0.00144	CbGpPWpGaD
Anagrelide—CYP1A2—Metabolism of lipids and lipoproteins—PIP5K1B—chronic kidney failure	0.000908	0.00142	CbGpPWpGaD
Anagrelide—PDE3A—GPCR downstream signaling—F2—chronic kidney failure	0.000907	0.00141	CbGpPWpGaD
Anagrelide—PDE3A—Signaling Pathways—DRD1—chronic kidney failure	0.000905	0.00141	CbGpPWpGaD
Anagrelide—PDE3A—Signaling Pathways—CYBA—chronic kidney failure	0.000876	0.00137	CbGpPWpGaD
Anagrelide—CYP1A2—Metabolism of lipids and lipoproteins—LCAT—chronic kidney failure	0.000873	0.00136	CbGpPWpGaD
Anagrelide—CYP1A2—Biological oxidations—CYP1A1—chronic kidney failure	0.000858	0.00134	CbGpPWpGaD
Anagrelide—CYP1A2—Metapathway biotransformation—CYP1A1—chronic kidney failure	0.000846	0.00132	CbGpPWpGaD
Anagrelide—PDE3A—GPCR downstream signaling—POMC—chronic kidney failure	0.000826	0.00129	CbGpPWpGaD
Anagrelide—PDE3A—Signaling by GPCR—F2—chronic kidney failure	0.000824	0.00128	CbGpPWpGaD
Anagrelide—PDE3A—Hemostasis—VEGFA—chronic kidney failure	0.000822	0.00128	CbGpPWpGaD
Anagrelide—CYP1A2—Metabolism of lipids and lipoproteins—PRKAG2—chronic kidney failure	0.000778	0.00121	CbGpPWpGaD
Anagrelide—CYP1A2—Metabolism of lipids and lipoproteins—PRKD1—chronic kidney failure	0.000778	0.00121	CbGpPWpGaD
Anagrelide—PDE3A—Signaling Pathways—HBEGF—chronic kidney failure	0.000769	0.0012	CbGpPWpGaD
Anagrelide—PDE3A—Hemostasis—TGFB1—chronic kidney failure	0.000754	0.00118	CbGpPWpGaD
Anagrelide—PDE3A—Signaling by GPCR—POMC—chronic kidney failure	0.000751	0.00117	CbGpPWpGaD
Anagrelide—PDE3A—Signaling by GPCR—CCL2—chronic kidney failure	0.000734	0.00115	CbGpPWpGaD
Anagrelide—CYP1A2—Metabolism of lipids and lipoproteins—SREBF2—chronic kidney failure	0.000728	0.00114	CbGpPWpGaD
Anagrelide—CYP1A2—Metabolism of lipids and lipoproteins—ABCC3—chronic kidney failure	0.000703	0.0011	CbGpPWpGaD
Anagrelide—PDE3A—Hemostasis—KRAS—chronic kidney failure	0.000699	0.00109	CbGpPWpGaD
Anagrelide—CYP1A2—Metabolism of lipids and lipoproteins—LPIN1—chronic kidney failure	0.000688	0.00107	CbGpPWpGaD
Anagrelide—CYP1A2—Metabolism of lipids and lipoproteins—LRP2—chronic kidney failure	0.000674	0.00105	CbGpPWpGaD
Anagrelide—PDE3A—Signaling Pathways—AVP—chronic kidney failure	0.000667	0.00104	CbGpPWpGaD
Anagrelide—CYP1A2—Biological oxidations—POMC—chronic kidney failure	0.00064	0.000997	CbGpPWpGaD
Anagrelide—PDE3A—Signaling Pathways—EDN1—chronic kidney failure	0.000635	0.00099	CbGpPWpGaD
Anagrelide—PDE3A—Signaling Pathways—CCL5—chronic kidney failure	0.00063	0.000982	CbGpPWpGaD
Anagrelide—PDE3A—Signaling Pathways—LPL—chronic kidney failure	0.000616	0.00096	CbGpPWpGaD
Anagrelide—CYP1A2—Metabolism—FABP1—chronic kidney failure	0.000603	0.000941	CbGpPWpGaD
Anagrelide—PDE3A—Signaling Pathways—NGF—chronic kidney failure	0.000583	0.000909	CbGpPWpGaD
Anagrelide—CYP1A2—Metabolism of lipids and lipoproteins—CPT1A—chronic kidney failure	0.000573	0.000894	CbGpPWpGaD
Anagrelide—CYP1A2—Metabolism—GATM—chronic kidney failure	0.000572	0.000892	CbGpPWpGaD
Anagrelide—CYP1A2—Metabolism—AGXT—chronic kidney failure	0.000572	0.000892	CbGpPWpGaD
Anagrelide—PDE3A—Signaling Pathways—CCR5—chronic kidney failure	0.000567	0.000885	CbGpPWpGaD
Anagrelide—CYP1A2—Metabolism of lipids and lipoproteins—LIPC—chronic kidney failure	0.000559	0.000872	CbGpPWpGaD
Anagrelide—CYP1A2—Metabolism of lipids and lipoproteins—CYP2C19—chronic kidney failure	0.000559	0.000872	CbGpPWpGaD
Anagrelide—CYP1A2—Metabolism—ACAT1—chronic kidney failure	0.000523	0.000816	CbGpPWpGaD
Anagrelide—CYP1A2—Metabolism of lipids and lipoproteins—SCARB1—chronic kidney failure	0.000516	0.000805	CbGpPWpGaD
Anagrelide—CYP1A2—Metabolism of lipids and lipoproteins—PTGS1—chronic kidney failure	0.000511	0.000797	CbGpPWpGaD
Anagrelide—CYP1A2—Metabolism of lipids and lipoproteins—SREBF1—chronic kidney failure	0.000501	0.000782	CbGpPWpGaD
Anagrelide—CYP1A2—Metabolism of lipids and lipoproteins—HMGCR—chronic kidney failure	0.000488	0.00076	CbGpPWpGaD
Anagrelide—PDE3A—Signaling Pathways—F2—chronic kidney failure	0.000487	0.000759	CbGpPWpGaD
Anagrelide—CYP1A2—Metabolism—MLXIPL—chronic kidney failure	0.000486	0.000758	CbGpPWpGaD
Anagrelide—CYP1A2—Metabolism of lipids and lipoproteins—FASN—chronic kidney failure	0.000477	0.000744	CbGpPWpGaD
Anagrelide—PDE3A—Signaling Pathways—IRS1—chronic kidney failure	0.00046	0.000718	CbGpPWpGaD
Anagrelide—CYP1A2—Metabolism—SLC22A2—chronic kidney failure	0.000445	0.000693	CbGpPWpGaD
Anagrelide—PDE3A—Signaling Pathways—POMC—chronic kidney failure	0.000443	0.000691	CbGpPWpGaD
Anagrelide—CYP1A2—Metabolism of lipids and lipoproteins—ABCA1—chronic kidney failure	0.000435	0.000678	CbGpPWpGaD
Anagrelide—PDE3A—Signaling Pathways—CCL2—chronic kidney failure	0.000434	0.000676	CbGpPWpGaD
Anagrelide—PDE3A—Signaling Pathways—IGF1—chronic kidney failure	0.000426	0.000665	CbGpPWpGaD
Anagrelide—CYP1A2—Metabolism—ABCG1—chronic kidney failure	0.000413	0.000645	CbGpPWpGaD
Anagrelide—PDE3A—Signaling Pathways—SERPINE1—chronic kidney failure	0.000405	0.000632	CbGpPWpGaD
Anagrelide—CYP1A2—Metabolism—PIP5K1B—chronic kidney failure	0.000405	0.000631	CbGpPWpGaD
Anagrelide—PDE3A—Signaling by GPCR—KRAS—chronic kidney failure	0.000401	0.000625	CbGpPWpGaD
Anagrelide—CYP1A2—Metabolism—ARG2—chronic kidney failure	0.000396	0.000618	CbGpPWpGaD
Anagrelide—CYP1A2—Metabolism—LCAT—chronic kidney failure	0.000389	0.000606	CbGpPWpGaD
Anagrelide—PDE3A—Signaling Pathways—NOS3—chronic kidney failure	0.000387	0.000603	CbGpPWpGaD
Anagrelide—PDE3A—Signaling Pathways—RELA—chronic kidney failure	0.000364	0.000568	CbGpPWpGaD
Anagrelide—CYP1A2—Metabolism—DDC—chronic kidney failure	0.000357	0.000556	CbGpPWpGaD
Anagrelide—CYP1A2—Metabolism—PRKAG2—chronic kidney failure	0.000346	0.00054	CbGpPWpGaD
Anagrelide—CYP1A2—Metabolism—CYP2B6—chronic kidney failure	0.000346	0.00054	CbGpPWpGaD
Anagrelide—CYP1A2—Metabolism—PRKD1—chronic kidney failure	0.000346	0.00054	CbGpPWpGaD
Anagrelide—CYP1A2—Metabolism of lipids and lipoproteins—LPL—chronic kidney failure	0.000341	0.000532	CbGpPWpGaD
Anagrelide—CYP1A2—Metabolism of lipids and lipoproteins—CYP1A1—chronic kidney failure	0.000329	0.000514	CbGpPWpGaD
Anagrelide—PDE3A—Signaling by GPCR—IL6—chronic kidney failure	0.000326	0.000509	CbGpPWpGaD
Anagrelide—CYP1A2—Metabolism—SREBF2—chronic kidney failure	0.000324	0.000506	CbGpPWpGaD
Anagrelide—CYP1A2—Metabolism—GCKR—chronic kidney failure	0.000313	0.000489	CbGpPWpGaD
Anagrelide—CYP1A2—Metabolism—ABCC3—chronic kidney failure	0.000313	0.000489	CbGpPWpGaD
Anagrelide—PDE3A—Signaling Pathways—NFKB1—chronic kidney failure	0.000307	0.000479	CbGpPWpGaD
Anagrelide—CYP1A2—Metabolism—LPIN1—chronic kidney failure	0.000307	0.000478	CbGpPWpGaD
Anagrelide—CYP1A2—Metabolism of lipids and lipoproteins—PPARA—chronic kidney failure	0.000301	0.00047	CbGpPWpGaD
Anagrelide—CYP1A2—Metabolism—LRP2—chronic kidney failure	0.0003	0.000468	CbGpPWpGaD
Anagrelide—CYP1A2—Metabolism—CYP2C18—chronic kidney failure	0.0003	0.000468	CbGpPWpGaD
Anagrelide—PDE3A—Signaling Pathways—VEGFA—chronic kidney failure	0.000279	0.000434	CbGpPWpGaD
Anagrelide—PDE3A—Signaling Pathways—TGFB1—chronic kidney failure	0.000256	0.000399	CbGpPWpGaD
Anagrelide—CYP1A2—Metabolism—CPT1A—chronic kidney failure	0.000255	0.000398	CbGpPWpGaD
Anagrelide—CYP1A2—Metabolism—LIPC—chronic kidney failure	0.000249	0.000388	CbGpPWpGaD
Anagrelide—CYP1A2—Metabolism—CYP2C19—chronic kidney failure	0.000249	0.000388	CbGpPWpGaD
Anagrelide—CYP1A2—Metabolism of lipids and lipoproteins—POMC—chronic kidney failure	0.000246	0.000383	CbGpPWpGaD
Anagrelide—PDE3A—Signaling Pathways—KRAS—chronic kidney failure	0.000237	0.000369	CbGpPWpGaD
Anagrelide—CYP1A2—Metabolism—SCARB1—chronic kidney failure	0.00023	0.000359	CbGpPWpGaD
Anagrelide—CYP1A2—Metabolism—PTGS1—chronic kidney failure	0.000228	0.000355	CbGpPWpGaD
Anagrelide—CYP1A2—Metabolism of lipids and lipoproteins—ALB—chronic kidney failure	0.000224	0.000349	CbGpPWpGaD
Anagrelide—CYP1A2—Metabolism—SREBF1—chronic kidney failure	0.000223	0.000348	CbGpPWpGaD
Anagrelide—CYP1A2—Metabolism—HMGCR—chronic kidney failure	0.000217	0.000339	CbGpPWpGaD
Anagrelide—CYP1A2—Metabolism—FASN—chronic kidney failure	0.000213	0.000331	CbGpPWpGaD
Anagrelide—CYP1A2—Metabolism—CYP3A4—chronic kidney failure	0.000197	0.000307	CbGpPWpGaD
Anagrelide—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—chronic kidney failure	0.000196	0.000305	CbGpPWpGaD
Anagrelide—CYP1A2—Metabolism—ABCA1—chronic kidney failure	0.000194	0.000302	CbGpPWpGaD
Anagrelide—PDE3A—Signaling Pathways—IL6—chronic kidney failure	0.000193	0.0003	CbGpPWpGaD
Anagrelide—CYP1A2—Metabolism—CAT—chronic kidney failure	0.000164	0.000256	CbGpPWpGaD
Anagrelide—CYP1A2—Metabolism—ABCB1—chronic kidney failure	0.000159	0.000249	CbGpPWpGaD
Anagrelide—CYP1A2—Metabolism—LPL—chronic kidney failure	0.000152	0.000237	CbGpPWpGaD
Anagrelide—CYP1A2—Metabolism—CYP1A1—chronic kidney failure	0.000147	0.000229	CbGpPWpGaD
Anagrelide—CYP1A2—Metabolism—MTHFR—chronic kidney failure	0.000137	0.000213	CbGpPWpGaD
Anagrelide—CYP1A2—Metabolism—PPARA—chronic kidney failure	0.000134	0.000209	CbGpPWpGaD
Anagrelide—CYP1A2—Metabolism—POMC—chronic kidney failure	0.000109	0.000171	CbGpPWpGaD
Anagrelide—CYP1A2—Metabolism—ALB—chronic kidney failure	9.97e-05	0.000155	CbGpPWpGaD
Anagrelide—CYP1A2—Metabolism—NOS3—chronic kidney failure	9.54e-05	0.000149	CbGpPWpGaD
Anagrelide—CYP1A2—Metabolism—PTGS2—chronic kidney failure	8.72e-05	0.000136	CbGpPWpGaD
